Role of fibrinolysis in obesity and thrombosis

Thrombosis Research

Volumn 123, Issue SUPPL. 4, 2009, Pages

  Lijnen, H R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Adipose tissue; Fibrinolysis; Obesity; Thrombosis

Indexed keywords

FIBRIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADIPOGENESIS; ANGIOGENESIS; ARTICLE; FIBRINOLYSIS; HUMAN; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; THROMBOSIS; TRANSGENIC MOUSE; VEIN THROMBOSIS;

EID: 62249216404     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(09)70143-4     Document Type: Article

References (17)

1. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., and Flegal K.M. Prevalence of overweight and obesity among US children, adolescents, and adults 1999 2000. JAMA 291 (2004) 2847-2850
2. Kopelman P.G. Obesity as a medical problem. Nature 404 (2000) 635-643
3. Pomp E.R., le Cessie S., Rosendaal F.R., and Doggen C.J. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 139 (2007) 289-296
4. Crandall D.L., Hausman E.J., and Kral J.G. A review of the microcirculation of adipose tissue: anatomic, metabolic and angiogenic perspectives. Microcirculation 4 (1997) 211-232
5. Lijnen H.R., and Collen D. Molecular and cellular basis of fibrinolysis. In: Hoffman R., Benz E.J., Shattil S.J., Furie B., Cohen H.J., Silberstein L.E., and McGlave P. (Eds). Hematology: basic principles and practice. 4th edition (2005), Elsevier, Philadelphia 1955-1959
6. Morange P.E., Bastelica D., Bonzi M.F., Van Hoef B., Collen D., Juhan-Vague I., et al. Influence of t-PA and u-PA on adipose tissue development in a murine model of diet-induced obesity. Thromb Haemost 87 (2002) 306-310
7. Hoover-Plow J., Ellis J., and Yuen L. In vivo plasminogen deficiency reduces fat accumulation. Thromb Haemost 87 (2002) 1011-1019
8. Lijnen H.R. Deficiency of a2-antiplasmin does not affect murine adipose tissue development. Thromb Haemost 5 (2007) 420-421
9. Lijnen H.R. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 3 (2005) 35-45
10. Morange P.E., Lijnen H.R., Alessi M.C., Kopp F., Collen D., and Juhan-Vague I. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 20 (2000) 1150-1154
11. Schäfer K., Fujisawa K., Konstantinides S., and Loskutoff D.J. Disruption of the plasminogen activator inhibitor-1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 15 (2001) 1840-1842
12. Ma L.F., Mao S.L., Taylor K.L., Kanjanabuch T., Guan Y., Zhang Y., et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor-1. Diabetes 53 (2004) 336-346
13. Lijnen H.R. Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice. Thromb Haemost 93 (2005) 816-819
14. Lijnen H.R., Maquoi E., Morange P.E., Voros G., Van Hoef B., Kopp F., et al. Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 23 (2003) 78-84
15. Eitzman D.T., Westrick R.J., Nabel E.G., and Ginsburg D. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 95 (2000) 577-580
16. Nagai N., Hoylaerts M., Cleuren A.C., Van Vlijmen B.J., and Lijnen H.R. Obesity promotes injury induced femoral artery thrombosis in mice. Thromb Res 122 (2008) 549-555
17. Nagai N., Van Hoef B., and Lijnen H.R. Plasminogen activator inhibitor-1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice. J Thromb Haemost 5 (2007) 1726-1731